A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

<p>Abstract</p> <p>Background</p> <p>New-onset diabetes mellitus after transplantation (NODAT), a frequent and serious complication after transplantation, is associated with decreased graft and patient survival. Currently, it is diagnosed and treated primarily according...

Full description

Bibliographic Details
Main Authors: Hörl Walter H, Döller Dominik, Stemer Gunar, Hecking Manfred, Pleiner Johannes, Voigt Hans-Christian, Werzowa Johannes, Haidinger Michael, Weichhart Thomas, Säemann Marcus D
Format: Article
Language:English
Published: BMC 2010-10-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/11/1/91

Internet

http://www.trialsjournal.com/content/11/1/91

Similar Items